Publications by authors named "Hupe M"

Background: Data on infliximab efficacy in bio-exposed patients with ulcerative colitis (UC) are limited.

Aims: To evaluate infliximab effectiveness and its predictors in UC patients with prior exposure to subcutaneous (SC) anti-TNF agent.

Methods: In this multicenter retrospective study (8 centers), we included all consecutive UC patients with prior exposure to subcutaneous anti-TNF, starting infliximab for symptomatic UC, excluding acute severe colitis.

View Article and Find Full Text PDF

Background: In case of high risk of lymph node invasion after endoscopic resection (ER) of superficial esophageal squamous cell carcinoma (SCC), adjuvant chemoradiotherapy (CRT) can be an alternative to surgery. We assessed long-term clinical outcomes of adjuvant therapy by CRT after non-curative ER for superficial SCC.

Methods: We performed a retrospective multicenter study.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of ustekinumab and anti-TNF agents as first-line treatments in biologic-naïve patients with luminal Crohn's disease, focusing on clinical response rates at 3 months.
  • A total of 206 biologic-naïve patients (156 on anti-TNF agents and 50 on ustekinumab) were evaluated, with response rates at 3 months showing 64% for ustekinumab and 86% for anti-TNF agents, indicating a significant advantage for anti-TNF therapy (P = .01).
  • The findings suggest that anti-TNF agents lead to higher response rates within 3 months compared to ustekinumab, although no significant
View Article and Find Full Text PDF

Purpose: To date, over 4.2 million Germans and over 235 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Uro-oncology (UO) patients are particularly vulnerable but in urgent need of life-saving systemic treatments.

View Article and Find Full Text PDF

Introduction: Guideline recommendations are meant to help minimize morbidity and to improve the care of nonmuscle invasive bladder cancer (NMIBC) patients but studies have suggested an underuse of guideline-recommended care. The aim of this study was to evaluate the level of adherence of German and Austrian urologists to German guideline recommendations.

Methods: A survey of 27 items evaluating diagnostic and therapeutic recommendations (15 cases of strong consensus and 6 cases of consensus) for NMIBC was administered among 14 urologic training courses.

View Article and Find Full Text PDF

Tripartite motif (TRIM) family proteins are post-translational protein modifiers with E3-ubiquitin ligase activity, thereby involved in various biological processes. The molecular mechanisms driving prostate cancer (PCa) bone metastasis (BM) are incompletely understood, and targetable genetic alterations are lacking in the majority of cases. Therefore, we aimed to explore the expression and potential functional relevance of 71 TRIM members in bone metastatic PCa.

View Article and Find Full Text PDF

High-grade prostatic intraepithelial neoplasia (HGPIN) is a facultative precursor lesion of prostate cancer (PCa). Multifocal HGPIN in needle biopsies in the absence of PCa indicates a higher risk of cancer detection in subsequent biopsies. Therefore, a reliable diagnosis of HGPIN is of high clinical relevance guiding the management of patients with cancer-negative biopsies.

View Article and Find Full Text PDF

Cancer diagnostics can be supplemented by disease-related biomarkers. In the course of modern patient-tailored cancer treatment, the importance of correct risk stratification, prognosis and monitoring has significantly increased. In recent years, a multitude of biomarkers and related test procedures have emerged to fulfil this purpose.

View Article and Find Full Text PDF

Objective: Osteoprotective medications are a key element not only in the management of bone metastases of castration-resistant prostate cancer (mCRPC) but also of hormone-sensitive prostate cancer (mHSPC). Additionally, osteoprotective drugs can prevent androgen deprivation-induced bone loss. The aim of this study was to illustrate the practice pattern of osteoprotection for prostate cancer patients in Germany.

View Article and Find Full Text PDF

Purpose: Gemcitabine-based chemotherapy regimens are first-line for several advanced cancers. Because of better tolerability, gemcitabine + cisplatin is a preferred neoadjuvant, adjuvant, and/or palliative chemotherapy regimen for advanced bladder cancer. Nevertheless, predicting treatment failure and overcoming resistance remain unmet clinical needs.

View Article and Find Full Text PDF

Introduction: The goal was to determine risk factors for Clavien-Dindo (CD) grade ≥2 complications, with special focus on early postoperative systemic inflammatory response syndrome (SIRS), for flexible ureteroscopy (fURS).

Materials And Methods: A retrospective monocentric statistical analysis relating to 32 factors was performed with the χ2 test, Mann-Whitney U tests, and multivariate logistic regression.

Results: In total, 416 consecutive fURS performed between September 2013 and June 2017 were analyzed; 283 (68.

View Article and Find Full Text PDF

Background: Oral chemolitholysis is a noninvasive therapy for uric acid (UA) stones. Proper patient selection is crucial for success of the therapy.

Objective: To develop a nomogram for prediction of UA stones using parameters gathered during emergency work-up for flank pain.

View Article and Find Full Text PDF
Article Synopsis
  • - Intravesical chemotherapy is primarily used for urothelial neoplasia, with Bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) being the standard treatments, while gemcitabine is a less common alternative.
  • - The article emphasizes the importance of gemcitabine for treating non-muscle invasive bladder cancer, particularly in cases where standard treatments have failed.
  • - A rare case of inverted bladder papilloma, which is linked to non-muscle invasive bladder cancer, is presented, highlighting successful treatment with intravesical gemcitabine after unsuccessful BCG therapy and an allergic reaction to MMC.
View Article and Find Full Text PDF

Background: CRP-based scoring systems were found to correlate with survival in patients with urooncologic diseases. Our retrospective single-centre study aimed to confirm CRP as a prognostic parameter in patients with bladder cancer (BCa) undergoing radical cystectomy (RC) and, based on the findings, to develop our own outcome score for muscle-invasive bladder cancer (MIBC) patients undergoing RC in order to identify patients with a high risk of mortality.

Material And Methods: A total of 254 patients who underwent RC at Hanover Medical School between 1996 and 2007 were reviewed with a follow-up until autumn 2013.

View Article and Find Full Text PDF

Introduction: Partial nephrectomy (PN) has evolved into the surgical standard of care for localized renal lesions. Hemostatic agents (HA) support the surgeon in achieving local hemostasis during PN. We previously reported initial results with the HA Hemopatch in PN.

View Article and Find Full Text PDF

Introduction: For risk stratification of non-muscle invasive bladder cancer (NMIBC), the depth of stromal invasion can be further classified, where the lamina muscularis mucosae (MM) serves as a reference structure. While the overall identifiability of MM in standard transurethral specimens is low, en bloc resection may help in identification and overall orientation. The aims of this study were to report the detection rate of MM in en bloc resected bladder tumors (ERBT) and to provide real-world information on tissue stability and preservation of en bloc architecture during recovery and processing for histopathologic evaluation.

View Article and Find Full Text PDF

Introduction: Penile cancer (PeCa) is an orphan disease in European countries. The current guidelines are predominantly based on retrospective studies with a low level of evidence. In our study, we aimed to identify predictors for guideline-conform treatment and hypothesize that reference centers for PeCa and physicians' experience promote guideline compliance and therefore correct local tumor therapy.

View Article and Find Full Text PDF

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies, and the fifth leading cause of cancer related mortality in men. For advanced PCa, radical prostatectomy, radiotherapy, and/or long-term androgen deprivation therapy are the recommended treatment options. However, subsequent progression to metastatic disease after initial therapy results in low 5-year survival rates (29%).

View Article and Find Full Text PDF
Lean Library.

J Med Libr Assoc

July 2020

Delft 48, 2611 CD Delft, Netherlands; https://www.leanlibrary.com/; three modules are available under the umbrella product of Lean Library: Library Access, Library Assist, and Library Alternatives; pricing is based partially on the number of modules implemented; libraries should contact the vendor for pricing.

View Article and Find Full Text PDF

Purpose: Radiological parameters predicting a postoperative stone-free status (SFS) or a complicated perioperative course of mini-PNL, are scarce. Our aim was to identify such factors for prone 17.5F mini-PNL.

View Article and Find Full Text PDF
Article Synopsis
  • Checkpoint inhibitors like Atezolizumab, Nivolumab, and Pembrolizumab provide a new treatment option for patients with urothelial cancer, which traditionally has a poor prognosis.
  • In a study of 28 patients who received monotherapy after chemotherapy, the median progression-free survival (PFS) was 5.8 months, while the median overall survival (OS) was 10.0 months, with an overall response rate of 21.4%.
  • Adverse events occurred in 71.4% of patients, with 39.3% experiencing higher-grade adverse events; however, no therapy-related deaths were reported, indicating a promising safety profile.
View Article and Find Full Text PDF

Background: Few data exist to help select a second biologic agent in patients with refractory ulcerative colitis (UC).

Aim: To compare the efficacy of infliximab (IFX) and vedolizumab (VDZ) in UC patients who failed a first subcutaneous anti-tumor necrosing factor (TNF) agent.

Methods: Consecutive UC patients from 12 French centres starting IFX or VDZ after at least one injection of adalimumab or golimumab have been included in a retrospective study.

View Article and Find Full Text PDF

Introduction: Multiparametric magnetic resonance imaging (mpMRI)/ultrasound fusion-guided biopsy, in short "targeted biopsy (TB)", is becoming more attractive as it improves the detection of clinically significant prostate cancer (CaP). The accuracy of fusion-guided biopsies is limited due to false positive radiological findings as well as to histological evidence for cancer in radiologically inconspicuous regions of the prostate. We aimed to analyze histomorphological findings on mpMRI lesions highly suspicious for CaP classified as PI-RADS 4 or PI-RADS 5 (Prostate Imaging - Recording and Data System) but cancer-negative in the biopsy of this region of interest (ROI), and to compare them with findings in radiologically inconspicuous regions.

View Article and Find Full Text PDF

Introduction: The aim of this study was to analyze the influence of residents' participation in flexible ureteroscopy (fURS) on intra- and postoperative outcomes.

Materials And Methods: Intra- and postoperative parameters were compared in a retrospective monocentric setting between 3 groups: "resident group" (47 cases) for surgeries performed by experienced residents alone, "consultant group" (245 cases) for surgeries performed by consultants alone, "resident plus consultant group" (124 cases) for training surgeries between September 2013 and June 2017.

Results: Patients operated by residents alone had a significantly smaller median kidney stone diameter (5.

View Article and Find Full Text PDF